Management of Intraductal Papillary Mucinous Neoplasms: Controversies in Guidelines and Future Perspectives
Authors:
Open Access
- 8 September 2018
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Gastroenterology
- Vol. 16 (3) , 316-332
Abstract
Purpose of review Management of intraductal papillary mucinous neoplasm (IPMN) is currently based on consensus, in the absence of evidence-based guidelines. In recent years, several consensus guidelines have been published, with distinct management strategies. In this review, we will discuss these discrepancies, in order to guide treating physicians in clinical management. Recent findings The detection rate of pancreatic cysts has increased substantially with the expanded use of high-quality imaging techniques to up to 45%. Of these cysts, 24–82% are IPMNs, which harbour a malignant potential. Timely detection of high-risk lesions is therefore of great importance. Surgical management is based on the presence of clinical and morphological high-risk features, yet the majority of resected specimens appear to be low risk. Summary International collaboration and incentive large-scale prospective registries of individuals undergoing cyst surveillance are needed to accumulate unbiased data and develop evidence-based guidelines. Additionally, development of non-invasive, accurate diagnostic tools (e.g. biomarkers) is needed to differentiate between neoplastic and non-neoplastic pancreatic cysts and detect malignant transformation at an early stage (i.e. high-grade dysplasia).Keywords
Funding Information
- University Medical Center Rotterdam
This publication has 121 references indexed in Scilit:
- PAM4 enzyme immunoassay alone and in combination with CA 19‐9 for the detection of pancreatic adenocarcinomaCancer, 2012
- Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial NeoplasiaGastroenterology, 2012
- Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasmHPB, 2011
- Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst DevelopmentScience Translational Medicine, 2011
- Role of EUS-FNA-Based Cytology in the Diagnosis of Mucinous Pancreatic Cystic Lesions: A Systematic Review and Meta-AnalysisDigestive Diseases and Sciences, 2010
- Asymptomatic Pancreatic Cystic Neoplasms: Maximizing Survival and Quality of Life Using Markov-Based Clinical NomogramsGastroenterology, 2010
- Mucin-Producing Neoplasms of the Pancreas: An Analysis of Distinguishing Clinical and Epidemiologic CharacteristicsClinical Gastroenterology and Hepatology, 2010
- Patient outcomes after total pancreatectomy: a single centre contemporary experienceHPB, 2009
- Long‐term follow up results of intraductal papillary mucinous tumors of pancreasJournal of Gastroenterology and Hepatology, 2005
- Assessment of complications of EUS-guided fine-needle aspirationGastrointestinal Endoscopy, 2001